PA
VLY icon

PharVision Advisers’s Valley National Bancorp VLY Stock Holding History

PharVision Advisers’s Portfolio VLY Stock Details VLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,368
Closed -$191K – 636
2025
Q4 		$191K Buy
+16,368
New +$182K 0.1% 577

Other funds holding VLY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return

PharVision Advisers's VLY Position: Q1 2026 in Review

PharVision Advisers sold out of Valley National Bancorp (VLY) in Q1 2026, closing a stake of 16,368 shares — an estimated $191K sold.

PharVision Advisers first reported a position in VLY in Q4 2025 and held it in 1 quarter. The position peaked at $191K in Q4 2025. 463 funds tracked by Wall St. Rank hold VLY as of Q1 2026.

  • PharVision Advisers reported no remaining Valley National Bancorp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 16,368 Valley National Bancorp shares in Q1 2026, an estimated $191K.
  • PharVision Advisers first reported a position in Valley National Bancorp in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Valley National Bancorp position peaked at $191K in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Valley National Bancorp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.